AG0035W0

Name: (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
Brand: Angene Chemical
SKU: AG0035W0

25316-40-9 | (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride

Chemical structure of (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride, CAS 25316-40-9

AG0035W0

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

CAS Number	25316-40-9
Catalog Number	AG0035W0(AGN-PC-0R13TA)
Chemical Name	(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
EC Number	246-818-3
IUPAC Name	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
InChI	InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1
InChI Key	MWWSFMDVAYGXBV-RUELKSSGSA-N
MDL Number	MFCD00077757
Molecular Formula	C27H30ClNO11
Molecular Weight	579.9802
SMILES	Oc1c2c([C@@H](O[C@H]3C[C@H](N)[C@@H]([C@@H](O3)C)O)C[C@@](C2)(C(=O)CO)O)c(c2c1C(=O)c1c(C2=O)c(OC)ccc1)O.Cl
UNII	82F2G7BL4E
Synonyms	Adriablastin, Adriablastine, Adriamycin, Adriblastin, Adriblastina, Adriblastine, Adrimedac, DOXO cell, DOXO-cell, Doxolem, Doxorubicin, Doxorubicin Hexal, Doxorubicin Hydrochloride, Doxorubicin NC, Doxorubicina Ferrer Farm, Doxorubicina Funk, Doxorubicina Tedec, Doxorubicine Baxter, Doxotec, Farmiblastina, Hydrochloride, Doxorubicin, Myocet, Onkodox, Ribodoxo, Rubex, Urokit Doxo cell, Urokit Doxo-cell, Doxorubicin Hydrochloride, 25316-40-9, Doxorubicin HCl, Hydroxydaunorubicin hydrochloride, Adriacin, Adriblastina, Rubex, ADRIAMYCIN HYDROCHLORIDE, Doxorubicin (Adriamycin) HCl, Adriamycin PFS, Adriamycin RDF, Doxorubicin (hydrochloride), UNII-82F2G7BL4E, Caelyx, ADRIAMYCIN, HYDROCHLORIDE, KW-125, Adriblastin, NSC 123127, Lipodox, MLS001401460, 82F2G7BL4E, Resmycin, Hydroxydaunorubicin, CPD000058570, SMR000058570, DSSTox_CID_10636, DSSTox_RID_78854, DSSTox_RID_80678, DSSTox_GSID_30636, DSSTox_GSID_45111, CCRIS 740, CAS-NOCAS_45111, Adrosal, Duxocin, Adriamycin hydrochloride-DNA complex, EINECS 246-818-3, MLS000028393, Lipo-Dox, (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride, SR-01000003049, doxorubicin.HCl, Doxorubicin, HCl, NSC-123127, Adriamycin (TN), DOX base, Adriacin (TN), (1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside hydrochloride, (8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride, (8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride, Prestwick_188, Doxorubicin hydrochloride [USP:JAN], MFCD00077757, Doxil (TN), Rubex (TN), Doxorubicin, free base, AC1L9FFU, Adriblastina hydrochloride, (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride, DOX, NCGC00163543-01, SCHEMBL3242, CAS-25316-40-9, MLS000049969, MLS000049970, MLS000049971, MLS000070047, MLS000392861, MLS000392871, MLS000392881, MLS000392891, MLS000392901, MLS000759533, MLS001055359, Doxorubicin Hydrochloride,(S), CHEMBL359744, DTXSID3030636, CHEBI:31522, AOB5216, BID0120, Doxorubicin hydrochloride solution, MWWSFMDVAYGXBV-RUELKSSGSA-N, ZX-AFC000216, BCPP000429, HMS1569G18, KUC110341C, (8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride, 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-, 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8S-cis)-, EX-A1337, Tox21_110050, Tox21_112061, Tox21_202483, Adriamycin (Doxorubicin Hydrochloride, CD0186, s1208, AKOS007930231, AKOS015920241, Doxorubicin hydrochloride (JP17/USP), Tox21_110050_1, BCP9000237, CCG-100975, CS-1239, MCULE-5540454667, NC00225, RL02839, SB21800, NCGC00014486-01, NCGC00024415-33, NCGC00024415-36, NCGC00260032-01, NCGC00263918-03, AS-31687, BR-72874, HY-15142, SAM001246768, KSC-230-184-1, AB0069925, ST2419270, FT-0082477, D01275, W-5070, 33804-EP2275420A1, 33804-EP2295055A2, 33804-EP2295416A2, 33804-EP2298748A2, 33804-EP2298764A1, 33804-EP2298765A1, 33804-EP2305642A2, 33804-EP2308833A2, 33804-EP2311453A1, 139293-EP2270008A1, 139293-EP2292617A1, 316D409, Doxorubicin hydrochloride, 98.0-102.0% (HPLC), SR-01000003049-5, SR-01000003049-10, Z1557399790, Doxorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard, Doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC), Doxorubicin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Doxorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard, (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride, (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hy, (8S,10S)-10-{[(2R,4S,5S,6S)-4-AMINO-5-HYDROXY-6-METHYLOXAN-2-YL]OXY}-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE HYDROCHLORIDE, 10-[(3-Amino-2,3,6-trideoxy-?-L-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione hydrochloride, 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-, Adriamycin, Doxil, doxorubicin, drochloride, Ellence, ADM hydrochloride, Adriblastina RD, Doxourbicin HCl, 2-Amino-3-chloropyrazine, D0F4KU, C27H29NO11.ClH, Doxorubicin hydrochloride [JAN], DRG-0047, FI 6804, C27-H29-N-O11.Cl-H, CID443939, ACN-036671, ACN-036867, A1832, A10041, 23214-92-8, Doxorubicin hydrochloride, 98%, an antibiotic agent - 1G 1g, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-, (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-, 5,12-NAPHTHACENEDIONE, 10-[(3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY]-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METOXY-, HYDROCHLORIDE, (8S-CIS)-,

Complexity	977
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	6
Defined Bond Stereocenter Count	0
Exact Mass	579.151g/mol
Formal Charge	0
Heavy Atom Count	40
Hydrogen Bond Acceptor Count	12
Hydrogen Bond Donor Count	7
Isotope Atom Count	0
Molecular Weight	579.983g/mol
Monoisotopic Mass	579.151g/mol
Rotatable Bond Count	5
Topological Polar Surface Area	206A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	\N
Hazard statements	H302-H315-H319-H335-H350-H360
Packing Group	\N
Precautionary statements	P261-P305+P351+P338
UN Code	\N

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited